Biosimilar Newsletter Archive
-
03.28.24 -- Meet "MAM," The New Quality Control Strategy On the Block
3/28/2024
03/28/24 Biosimilar Development Newsletter
-
03.22.24 -- Packaging And Containment Insights To Get To Market Faster
3/22/2024
03/22/24 Biosimilar Development Newsletter
-
03.21.24 -- Biosimilars Forum Urges Congress To Reform PBMs
3/21/2024
03/21/24 Biosimilar Development Newsletter
-
03.14.24 -- Understanding & Navigating Diverse Regulatory Environments
3/14/2024
03/14/24 Biosimilar Development Newsletter
-
03.07.24 -- Cardinal Health Report Examines Milestone Year In Biosimilars
3/7/2024
03/07/24 Biosimilar Development Newsletter
-
03.03.24 -- Samsung Bioepis Initiates Ph. 1 For Keytruda Biosimilar
3/3/2024
03/03/24 Biosimilar Development Newsletter
-
02.29.24 -- Samsung Bioepis Initiates Ph. 1 For Keytruda Biosimilar
2/29/2024
02/29/24 Biosimilar Development Newsletter
-
02.22.24 -- Analyzing & Kickstarting Organizational Quality Maturity
2/22/2024
02/22/24 Biosimilar Development Newsletter
-
02.15.24 -- How To Develop Innovative, Intuitive, Patient Friendly Drug Delivery Devices
2/15/2024
02/15/24 Biosimilar Development Newsletter
-
02.15.24 -- When Does Continuous Manufacturing Make Sense?
2/15/2024
02/15/24 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more